Armin Giese, Prof. Dr. med., MD, studied medicine in Kiel, Germany, and in London, where he obtained a BSc at University College London in 1992. He received scholarships from the German National Scholarship Foundation and from the DAAD. He started his clinical training in neuropathology at the University of Göttingen in 1994 and finished his doctoral thesis (summa cum laude) in 1999. In 2000 he moved to the Ludwig-Maximilians-University (LMU) in Munich, where he became full professor for neuropathology in 2008.
His scientific focus is the role of protein aggregation in neurodegenerative diseases. Dr. Giese developed new high-throughput methods for protein oligomer detection and for the screening of aggregation inhibitors based on single-particle spectroscopy. Using this technology, he identified novel aggregation inhibitors with excellent medicinal chemical properties and high in vivo efficacy. Based on these discoveries, he co-founded MODAG GmbH in 2013. He is acting head of the Center for Neuropathology and Prion Research of LMU and of the Reference Center for Neurodegenerative Diseases of the German Association for Neuropathology and Neuroanatomy.